Pictet Asset Management (UK)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pictet Asset Management (UK)'s BMY Position: Q2 2021 in Review
Pictet Asset Management (UK) reduced its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2021, selling an estimated $3.15M and leaving 1,044,959 shares worth $69.8M. The position accounts for 0.08% of the portfolio, ranked #284.
Pictet Asset Management (UK) first reported a position in BMY in Q2 2013 and has held it in 33 quarters since. The position peaked at $127M in Q2 2016. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Pictet Asset Management (UK) held 1,044,959 shares of Bristol-Myers Squibb worth $69.8M as of Q2 2021.
- Pictet Asset Management (UK) sold 48,253 Bristol-Myers Squibb shares in Q2 2021, an estimated $3.15M.
- Bristol-Myers Squibb made up 0.08% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #284 holding.
- Pictet Asset Management (UK) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 33 quarters since.
- Pictet Asset Management (UK)'s Bristol-Myers Squibb position peaked at $127M in Q2 2016.
- 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.